Company Description
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.
It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors.
The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.
| Country | Israel |
| Founded | 2001 |
| IPO Date | Sep 12, 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 108 |
| CEO | Lawrence J. Jasinski BS, MBA |
Contact Details
Address: 3 Hatnufa St., Floor 6 Yokneam Ilit, L3 2069203 Israel | |
| Phone | 97249590123 |
| Website | rewalk.com |
Stock Details
| Ticker Symbol | LFWD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001607962 |
| ISIN Number | IL0011331076 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Lawrence J. Jasinski BS, MBA | Chief Executive Officer and Director |
| Michael A. Lawless | Chief Financial Officer |
| Miri Pariente | Vice President of Operations, Regulatory and Quality |
| Jeannine Lynch | Vice President of Market Access and Strategy |
| Kathleen O'Donnell | Vice President of Marketing and New Business Development |
| Charles Remsberg | Chief Sales Officer |
| Judy Kula | Vice President of Customer Service, Human Resources and Business Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 19, 2024 | 8-K | Current Report |
| Apr 4, 2024 | 8-K | Current Report |
| Apr 3, 2024 | 8-K | Current Report |
| Feb 27, 2024 | 10-K | Annual Report |
| Feb 27, 2024 | 8-K | Current Report |
| Jan 30, 2024 | 8-K | Current Report |
| Dec 19, 2023 | 8-K | Current Report |
| Nov 20, 2023 | 144 | Filing |
| Nov 17, 2023 | 144 | Filing |
| Nov 14, 2023 | 10-Q | Quarterly Report |